Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Multiclass Classifier based Cardiovascular Condition Detection Using Smartphone Mechanocardiography.

Iftikhar Z, Lahdenoja O, Jafari Tadi M, Hurnanen T, Vasankari T, Kiviniemi T, Airaksinen J, Koivisto T, Pänkäälä M.

Sci Rep. 2018 Jun 19;8(1):9344. doi: 10.1038/s41598-018-27683-9.

2.

Optimal timing for cardioversion in patients with atrial fibrillation.

Hellman T, Kiviniemi T, Nuotio I, Biancari F, Vasankari T, Hartikainen J, Lehto M, Airaksinen KE; FinCV Investigators.

Clin Cardiol. 2018 May 26. doi: 10.1002/clc.22986. [Epub ahead of print]

3.

How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?

Lehtola H, Hartikainen J, Hartikainen P, Kiviniemi T, Nuotio I, Palomäki A, Ylitalo A, Airaksinen KEJ, Mustonen P.

Clin Cardiol. 2018 May;41(5):608-614. doi: 10.1002/clc.22935. Epub 2018 May 10.

4.

Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting.

Nammas W, Dalén M, Rosato S, Gherli R, Reichart D, Gatti G, Onorati F, Faggian G, De Feo M, Bancone C, Chocron S, Khodabandeh S, Santarpino G, Rubino AS, Maselli D, Nardella S, Salsano A, Gherli T, Nicolini F, Zanobini M, Saccocci M, Bounader K, D'Errigo P, Kiviniemi T, Kinnunen EM, Perrotti A, Airaksinen J, Mariscalco G, Ruggieri VG, Biancari F.

Platelets. 2018 Apr 20:1-7. doi: 10.1080/09537104.2018.1466389. [Epub ahead of print]

PMID:
29676943
5.

Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography: The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation).

Jaakkola J, Jaakkola S, Lahdenoja O, Hurnanen T, Koivisto T, Pänkäälä M, Knuutila T, Kiviniemi TO, Vasankari T, Airaksinen KEJ.

Circulation. 2018 Apr 3;137(14):1524-1527. doi: 10.1161/CIRCULATIONAHA.117.032804. Epub 2018 Mar 11. No abstract available.

PMID:
29526834
6.

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).

Jaakkola S, Kiviniemi TO, Nuotio I, Hartikainen J, Mustonen P, Palomäki A, Jaakkola J, Ylitalo A, Hartikainen P, Airaksinen KEJ.

Am J Cardiol. 2018 May 15;121(10):1182-1186. doi: 10.1016/j.amjcard.2018.01.038. Epub 2018 Feb 12.

PMID:
29526276
7.

Determinants of re-operation for bleeding in head and neck cancer surgery.

Haapio E, Kinnunen I, Airaksinen JKE, Irjala H, Kiviniemi T.

J Laryngol Otol. 2018 Apr;132(4):336-340. doi: 10.1017/S0022215118000294. Epub 2018 Mar 8.

PMID:
29517474
8.

Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement.

Kiviniemi T, Malmberg M, Biancari F, Hartikainen J, Ihlberg L, Yannopoulos F, Riekkinen T, von Hellens O, Lehto J, Nissinen M, Airaksinen KJ, Nieminen T.

Eur Heart J Qual Care Clin Outcomes. 2018 Apr 1;4(2):120-125. doi: 10.1093/ehjqcco/qcy003.

PMID:
29390053
9.

Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery.

Biancari F, Kinnunen EM, Kiviniemi T, Tauriainen T, Anttila V, Airaksinen JKE, Brascia D, Vasques F.

J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1618-1624. doi: 10.1053/j.jvca.2017.12.024. Epub 2017 Dec 13.

PMID:
29338997
10.

Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.

Nammas W, Kiviniemi T, Schlitt A, Rubboli A, Valencia J, Lip GYH, Karjalainen PP, Biancari F, Juhani Airaksinen KE.

Int J Cardiol. 2018 Feb 15;253:35-39. doi: 10.1016/j.ijcard.2017.07.074.

PMID:
29306469
11.

Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Lahtela HM, Bah A, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Karjalainen PP, Proietti M, Hartikainen JEK, Lip GYH, Airaksinen KEJ.

Clin Cardiol. 2017 Dec;40(12):1264-1270. doi: 10.1002/clc.22821. Epub 2017 Dec 15.

12.

Population trends in mitral valve surgery in Finland between 1997 and 2014: the finnish CVD register.

Myllykangas ME, Aittokallio JM, Pietilä A, Salomaa VV, Gunn JM, Kiviniemi TO, Niiranen TJ.

Scand Cardiovasc J. 2018 Feb;52(1):51-57. doi: 10.1080/14017431.2017.1405068. Epub 2017 Dec 3.

PMID:
29198154
13.

Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Virta A, Airaksinen KEJ.

Ann Med. 2018 Mar;50(2):164-171. doi: 10.1080/07853890.2017.1407494. Epub 2017 Nov 23.

PMID:
29156997
14.

Transfusion and blood stream infections after coronary surgery.

Tauriainen T, Kinnunen EM, Laitinen I, Anttila V, Kiviniemi T, Airaksinen JKE, Biancari F.

Interact Cardiovasc Thorac Surg. 2018 Feb 1;26(2):325-327. doi: 10.1093/icvts/ivx320.

PMID:
29049748
15.

Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study).

Lautamäki A, Gunn JM, Airaksinen KEJ, Biancari F, Kajander OA, Anttila V, Heikkinen J, Eskola M, Ilveskoski E, Mennander A, Korpilahti K, Wistbacka JO, Kiviniemi TO.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):101-106. doi: 10.1093/ehjqcco/qcw043.

PMID:
28927176
16.

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.

Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GY; AFCAS Study Group.

Am Heart J. 2017 Aug;190:86-93. doi: 10.1016/j.ahj.2017.05.016. Epub 2017 Jun 3.

PMID:
28760217
17.

Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.

Hellman T, Kiviniemi T, Nuotio I, Vasankari T, Hartikainen J, Lip GYH, Airaksinen KEJ.

Thromb Res. 2017 Aug;156:163-167. doi: 10.1016/j.thromres.2017.06.026. Epub 2017 Jun 22.

PMID:
28662483
18.

Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography.

Grönman M, Tarkia M, Kiviniemi T, Halonen P, Kuivanen A, Savunen T, Tolvanen T, Teuho J, Käkelä M, Metsälä O, Pietilä M, Saukko P, Ylä-Herttuala S, Knuuti J, Roivainen A, Saraste A.

J Transl Med. 2017 Jun 19;15(1):144. doi: 10.1186/s12967-017-1245-1.

19.

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Issakoff M, Airaksinen KEJ.

PLoS One. 2017 Apr 20;12(4):e0175975. doi: 10.1371/journal.pone.0175975. eCollection 2017.

20.

Atrial Fibrillation Detection via Accelerometer and Gyroscope of a Smartphone.

Lahdenoja O, Hurnanen T, Iftikhar Z, Nieminen S, Knuutila T, Saraste A, Kiviniemi T, Vasankari T, Airaksinen J, Pankaala M, Koivisto T.

IEEE J Biomed Health Inform. 2018 Jan;22(1):108-118. doi: 10.1109/JBHI.2017.2688473. Epub 2017 Apr 5.

PMID:
28391210
21.

Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.

Lehtola H, Airaksinen KEJ, Hartikainen P, Hartikainen JEK, Palomäki A, Nuotio I, Ylitalo A, Kiviniemi T, Mustonen P.

Eur J Neurol. 2017 May;24(5):719-725. doi: 10.1111/ene.13280. Epub 2017 Mar 20.

PMID:
28317289
22.

Detection of atrial fibrillation with seismocardiography.

Pankaala M, Koivisto T, Lahdenoja O, Kiviniemi T, Saraste A, Vasankari T, Airaksinen J.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4369-4374. doi: 10.1109/EMBC.2016.7591695.

PMID:
28269246
23.

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.

Hellman T, Kiviniemi T, Vasankari T, Nuotio I, Biancari F, Bah A, Hartikainen J, Mäkäräinen M, Airaksinen KE.

BMC Cardiovasc Disord. 2017 Jan 18;17(1):33. doi: 10.1186/s12872-017-0470-0.

24.

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GYH; AFCAS Study Group.

Clin Res Cardiol. 2017 Jun;106(6):420-427. doi: 10.1007/s00392-016-1071-0. Epub 2017 Jan 11.

25.

Stroke as the First Manifestation of Atrial Fibrillation.

Jaakkola J, Mustonen P, Kiviniemi T, Hartikainen JE, Palomäki A, Hartikainen P, Nuotio I, Ylitalo A, Airaksinen KE.

PLoS One. 2016 Dec 9;11(12):e0168010. doi: 10.1371/journal.pone.0168010. eCollection 2016.

26.

Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.

Varho V, Nammas W, Kiviniemi TO, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Karjalainen PP.

Int J Cardiol. 2017 Jan 15;227:194-200. doi: 10.1016/j.ijcard.2016.11.173. Epub 2016 Nov 9.

PMID:
27839810
27.

Automated Detection of Atrial Fibrillation Based on Time-Frequency Analysis of Seismocardiograms.

Hurnanen T, Lehtonen E, Tadi MJ, Kuusela T, Kiviniemi T, Saraste A, Vasankari T, Airaksinen J, Koivisto T, Pankaala M.

IEEE J Biomed Health Inform. 2017 Sep;21(5):1233-1241. doi: 10.1109/JBHI.2016.2621887. Epub 2016 Nov 4.

PMID:
27834656
28.

Trends in rates, patient selection and prognosis of coronary revascularisations in Finland between 1994 and 2013: the CVDR.

Kiviniemi TO, Pietilä A, Gunn JM, Aittokallio JM, Mähönen MS, Salomaa VV, Niiranen TJ.

EuroIntervention. 2016 Oct 20;12(9):1117-1125. doi: 10.4244/EIJV12I9A183.

29.

Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.

Palomäki A, Kiviniemi T, Mustonen P, Odei C, Hartikainen JEK, Nuotio I, Ylitalo A, Hartikainen P, Biancari F, Airaksinen KEJ.

Int J Cardiol. 2017 Jan 15;227:869-874. doi: 10.1016/j.ijcard.2016.06.107. Epub 2016 Jun 23.

PMID:
27639597
30.

Incidence and predictors of 30-day cardiovascular complications in patients undergoing head and neck cancer surgery.

Haapio E, Kiviniemi T, Irjala H, Koivunen P, Airaksinen JKE, Kinnunen I.

Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4601-4606. doi: 10.1007/s00405-016-4164-5. Epub 2016 Jul 4.

PMID:
27376645
31.

Excessive intravenous fluid therapy in head and neck cancer surgery.

Haapio E, Kinnunen I, Airaksinen JK, Irjala H, Kiviniemi T.

Head Neck. 2017 Jan;39(1):37-41. doi: 10.1002/hed.24525. Epub 2016 Jun 14.

PMID:
27299857
32.

Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.

Palomäki A, Kiviniemi T, Hartikainen JE, Mustonen P, Ylitalo A, Nuotio I, Hartikainen P, Jaakkola J, Luite R, Airaksinen KE.

Clin Cardiol. 2016 Aug;39(8):471-6. doi: 10.1002/clc.22554. Epub 2016 May 30.

33.

Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.

Varho V, Kiviniemi TO, Nammas W, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Mikkelsson J, Tuomainen P, Perälä A, Karjalainen PP.

Int J Cardiovasc Imaging. 2016 Jul;32(7):1031-9. doi: 10.1007/s10554-016-0871-7. Epub 2016 Apr 13.

PMID:
27076220
34.

Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide.

Nordling P, Kiviniemi T, Strandberg M, Strandberg N, Airaksinen J.

BMJ Open. 2016 Feb 24;6(2):e009416. doi: 10.1136/bmjopen-2015-009416.

35.

Occurrence of postpericardiotomy syndrome admissions: A population-based registry study.

Lehto J, Kiviniemi TO, Gunn J, Mustonen P, Airaksinen J, Biancari F, Rautava P, Sipilä J, Kytö V.

Ann Med. 2016;48(1-2):28-33. doi: 10.3109/07853890.2015.1122223. Epub 2015 Dec 15.

PMID:
26671291
36.

Strokes after cardioversion of atrial fibrillation--The FibStroke study.

Palomäki A, Mustonen P, Hartikainen JE, Nuotio I, Kiviniemi T, Ylitalo A, Hartikainen P, Lehtola H, Luite R, Airaksinen KE.

Int J Cardiol. 2016 Jan 15;203:269-73. doi: 10.1016/j.ijcard.2015.10.168. Epub 2015 Oct 20.

PMID:
26519683
37.

Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.

Palomäki A, Mustonen P, Hartikainen JE, Nuotio I, Kiviniemi T, Ylitalo A, Hartikainen P, Airaksinen KE.

Eur J Neurol. 2016 Jan;23(1):133-9. doi: 10.1111/ene.12820. Epub 2015 Aug 11.

PMID:
26263442
38.

Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.

Lautamäki A, Kiviniemi T, Biancari F, Airaksinen J, Juvonen T, Gunn J.

Eur J Cardiothorac Surg. 2016 Mar;49(3):926-30. doi: 10.1093/ejcts/ezv233. Epub 2015 Jul 4.

PMID:
26142469
39.

Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention.

Gunn J, Kiviniemi T, Biancari F, Kajander O, Mäkikallio T, Eskola M, Ilveskoski E, Korpilahti K, Wistbacka JO, Anttila V, Heikkinen J, Airaksinen J.

Scand J Work Environ Health. 2015 Sep 1;41(5):460-6. doi: 10.5271/sjweh.3508. Epub 2015 Jun 17.

40.

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial.

Lahtela HM, Kiviniemi TO, Puurunen MK, Schlitt A, Rubboli A, Ylitalo A, Valencia J, Lip GY, Airaksinen KE.

PLoS One. 2015 Jun 1;10(6):e0128492. doi: 10.1371/journal.pone.0128492. eCollection 2015.

41.

Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study.

Jaakkola J, Hartikainen JE, Kiviniemi T, Nuotio I, Nammas W, Grönberg T, Karmi A, Ylitalo A, Airaksinen KE.

Ann Med. 2015 Jun;47(4):341-5. doi: 10.3109/07853890.2015.1031821. Epub 2015 May 6.

PMID:
25943162
42.

Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: The Finland postpericardiotomy syndrome study.

Lehto J, Gunn J, Karjalainen P, Airaksinen J, Kiviniemi T.

J Thorac Cardiovasc Surg. 2015 May;149(5):1324-9. doi: 10.1016/j.jtcvs.2015.01.031. Epub 2015 Jan 21.

43.

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.

Kiviniemi T, Airaksinen KE, Rubboli A, Biancari F, Valencia J, Lip GY, Karjalainen PP, Weber M, Laine M, Kirchhof P, Schlitt A; AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) study group.

Int J Cardiol. 2015 Mar 15;183:105-10. doi: 10.1016/j.ijcard.2015.01.056. Epub 2015 Jan 27.

PMID:
25662060
44.

Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.

Jalkanen J, Yegutkin GG, Hollmén M, Aalto K, Kiviniemi T, Salomaa V, Jalkanen S, Hakovirta H.

Circ Res. 2015 Mar 27;116(7):1206-15. doi: 10.1161/CIRCRESAHA.116.305715. Epub 2015 Feb 2.

PMID:
25645301
45.

Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial.

Karjalainen PP, Varho V, Nammas W, Mikkelsson J, Pietilä M, Ylitalo A, Airaksinen JK, Sia J, Nyman K, Biancari F, Kiviniemi T.

Circ J. 2015;79(2):360-7. doi: 10.1253/circj.CJ-14-1000. Epub 2014 Dec 15.

46.

Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Kiviniemi T, Puurunen M, Schlitt A, Rubboli A, Karjalainen P, Nammas W, Kirchhof P, Biancari F, Lip GY, Airaksinen KJ.

Circ J. 2014;78(11):2674-81. Epub 2014 Oct 9.

47.

Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study.

Lautamäki A, Airaksinen KE, Kiviniemi T, Vinco G, Ribichini F, Gunn J, Anttila V, Heikkinen J, Korpilahti K, Karjalainen P, Kajander O, Eskola M, Ilveskoski E, Axelsson T, Gudbjartsson T, Jeppsson A, Biancari F.

Atherosclerosis. 2014 Aug;235(2):483-7. doi: 10.1016/j.atherosclerosis.2014.05.953. Epub 2014 Jun 9.

PMID:
24953487
48.

Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).

Biancari F, Gudbjartsson T, Heikkinen J, Anttila V, Mäkikallio T, Jeppsson A, Thimour-Bergström L, Mignosa C, Rubino AS, Kuttila K, Gunn J, Wistbacka JO, Teittinen K, Korpilahti K, Onorati F, Faggian G, Vinco G, Vassanelli C, Ribichini F, Juvonen T, Axelsson TA, Sigurdsson AF, Karjalainen PP, Mennander A, Kajander O, Eskola M, Ilveskoski E, D'Oria V, De Feo M, Kiviniemi T, Airaksinen KE.

Am J Cardiol. 2014 Jul 15;114(2):198-205. doi: 10.1016/j.amjcard.2014.04.025. Epub 2014 May 2.

PMID:
24878127
49.

Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture.

Hietala P, Strandberg M, Kiviniemi T, Strandberg N, Airaksinen KE.

Am J Cardiol. 2014 Jul 15;114(2):193-7. doi: 10.1016/j.amjcard.2014.04.026. Epub 2014 May 2.

PMID:
24856320
50.

Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Puurunen M, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Nyman K, Karjalainen P, Kirchhof P, Lip GY, Airaksinen JK.

BMJ Open. 2014 May 13;4(5):e004700. doi: 10.1136/bmjopen-2013-004700.

Supplemental Content

Loading ...
Support Center